Resverlogix Closes Previously Announced $87 Million Private Placement with Shenzhen Hepalink Dec 4, 2017
Market Constraints Cause Severe Shortage of Essential Pediatric Medicines in China Nov 29, 2017 Life Science
HitGen of Chengdu Forms Drug Discovery Partnership with Boehringer Ingelheim Nov 29, 2017 Life Science
Fullerton Raises $121 Million for China Healthcare Clinics; Ping An Leads Funding Nov 29, 2017 Life Science
Guangzhou RiboBio Partners with GE to Build Oligonucleotide CRO/CMO Facility Nov 21, 2017 Life Science
DelMar Presents Positive Interim Results from VAL-083 Study in MGMT-unmethylated Recurrent GBM at The Society for NeuroOncology Annual Meeting Nov 21, 2017 Life Science
Canada’s Acasti Signs $133 Million Non-Binding Term Sheet with China Pharma Nov 20, 2017 Life Science
Celgene Corporation and bluebird bio Announce bb2121 Anti-BCMA CAR-T Cell Therapy Has Been Granted Breakthrough Therapy Designation from FDA and Prime Eligibility from EMA for Relapsed and Refractory Multiple Myeloma Nov 17, 2017 Life Science
